Posts by Cal Merritt
Canaccord adjusts biotech targets on execution trends; Oppenheimer raises Ligand pharma outlook
3 perspectives
Trump's Truth Social offers paid early access to posts; legal experts question insider trading implications
3 perspectives
Morgan Stanley initiates coverage on ITG and Accor with mixed infrastructure and hospitality outlooks
3 perspectives
Singapore's central bank tightens policy for second straight time amid global oil price pressures
3 perspectives
Trump tariffs on Australia escalate amid claims of forced labour, drawing trade agreement challenge
3 perspectives
Canada signals tariff response as Trump administration links wildfires to trade negotiations
3 perspectives
Trump imposes 10-12.5% tariffs on 60 countries citing forced labor enforcement gaps
3 perspectives
Trump imposes 50% tariffs on Canadian goods including autos, dairy, alcohol
3 perspectives
Trump Media pitches $100,000 monthly fee for early access to president's posts
3 perspectives
Wall Street analysts raise price targets across sectors on operational improvements, company fundamentals
3 perspectives